Home
GMED
GMED News

Latest Globus Medical Inc. (GMED) News on January 18, 2025

Argus Research

4 days ago

GMED: Raising target price to $93.00

MT Newswires

4 days ago

Globus Medical Insider Sold Shares Worth $1,250,770, According to a Recent SEC Filing

Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector

Investor's Business Daily

8 days ago

Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector

These Oil And Gas Names Hit Highs As Energy Prices Jump

Investor's Business Daily

8 days ago

These Oil And Gas Names Hit Highs As Energy Prices Jump

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Zacks

8 days ago

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Globus Medical upgraded to Neutral from Underperform at BofA

TipRanks

8 days ago

Globus Medical upgraded to Neutral from Underperform at BofA

MT Newswires

10 days ago

Globus Medical Reports Preliminary Q4 Sales, Sets 2025 Guidance

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

GlobeNewswire

10 days ago

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

11 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Globus Medical Stock Revs Up For Next Move After 70% Run

Investor's Business Daily

12 days ago

Globus Medical Stock Revs Up For Next Move After 70% Run

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Zacks

16 days ago

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow

Zacks

25 days ago

4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow

Reasons to Add GMED Stock to Your Portfolio Right Now

Zacks

25 days ago

Reasons to Add GMED Stock to Your Portfolio Right Now

Argus Research

a month ago

GMED: Lowering target price to $87.00

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

Zacks

a month ago

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

Reasons to Ratain CVS Stock in Your Portfolio Now

Zacks

a month ago

Reasons to Ratain CVS Stock in Your Portfolio Now

Reasons to Retain ABT Stock in Your Portfolio Now

Zacks

a month ago

Reasons to Retain ABT Stock in Your Portfolio Now

Globus Medical price target raised to $90 from $85 at Truist

TipRanks

a month ago

Globus Medical price target raised to $90 from $85 at Truist

MT Newswires

a month ago

Truist Securities Adjusts Price Target on Globus Medical to $90 From $85, Keeps Hold Rating

MT Newswires

a month ago

RBC Raises Price Target on Globus Medical to $101 From $92, Keeps Outperform Rating

Argus Research

a month ago

GMED: Raising target price to $88.00

Reasons to Retain STE Stock in Your Portfolio Now

Zacks

a month ago

Reasons to Retain STE Stock in Your Portfolio Now

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Baxter Stock May Gain Following Five New Injectable Product Launches

Zacks

a month ago

Baxter Stock May Gain Following Five New Injectable Product Launches

Reasons to Retain Alcon Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Retain Alcon Stock in Your Portfolio for Now

Reasons to Retain PacBio Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Retain PacBio Stock in Your Portfolio for Now

MBOT Stock Gains Following FDA Submission of the LIBERTY System

Zacks

a month ago

MBOT Stock Gains Following FDA Submission of the LIBERTY System

Reasons to Retain Envista Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Retain Envista Stock in Your Portfolio for Now

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Zacks

a month ago

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Inari Medical Stock Gets RS Rating Upgrade

Investor's Business Daily

a month ago

Inari Medical Stock Gets RS Rating Upgrade

NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study

Zacks

a month ago

NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study

5 Medical Device Stocks That Survived the 2024 Market Volatility

Zacks

a month ago

5 Medical Device Stocks That Survived the 2024 Market Volatility

Argus Research

a month ago

GMED: Lowering target price to $87.00

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

Zacks

a month ago

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial

Zacks

a month ago

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial

Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

Zacks

a month ago

Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

Reasons to Retain ZBH Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Retain ZBH Stock in Your Portfolio for Now

Reasons to Retain TNDM Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Retain TNDM Stock in Your Portfolio for Now

What Makes Globus Medical (GMED) a New Buy Stock

Zacks

a month ago

What Makes Globus Medical (GMED) a New Buy Stock

GEHC Stock May Gain Following the Launches of Aurora and Clarify DL

Zacks

a month ago

GEHC Stock May Gain Following the Launches of Aurora and Clarify DL

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins

Zacks

a month ago

PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins

GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL

Zacks

a month ago

GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL

Reasons to Retain EYE Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Retain EYE Stock in Your Portfolio for Now

Argus Research

a month ago

GMED: What does Argus have to say about GMED?

Novocure Stock Earns 96 RS Rating

Investor's Business Daily

2 months ago

Novocure Stock Earns 96 RS Rating

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

Zacks

2 months ago

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

RDNT Stock Up Post New Tie-Up to Boost Ultrasound Workflows With AI

Zacks

2 months ago

RDNT Stock Up Post New Tie-Up to Boost Ultrasound Workflows With AI

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

2 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

HOLX Stock Set to Gain From New Study Data on Genius AI Detection 2.0

Zacks

2 months ago

HOLX Stock Set to Gain From New Study Data on Genius AI Detection 2.0

Is Penumbra Stock a Smart Buy for Your Portfolio Right Now?

Zacks

2 months ago

Is Penumbra Stock a Smart Buy for Your Portfolio Right Now?

Here's Why Globus Medical (GMED) is a Strong Value Stock

Zacks

2 months ago

Here's Why Globus Medical (GMED) is a Strong Value Stock

Why Is Globus Medical, Inc. (GMED) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insider Monkey

2 months ago

Why Is Globus Medical, Inc. (GMED) Among the Best High Growth Healthcare Stocks to Invest In Now?

RDNT Stock Up Following the New Tie-Up to Leverage Radiology AI

Zacks

2 months ago

RDNT Stock Up Following the New Tie-Up to Leverage Radiology AI

GEHC Stock May Gain Following the Launch of Sonic DL for 3D Imaging

Zacks

2 months ago

GEHC Stock May Gain Following the Launch of Sonic DL for 3D Imaging

Reasons to Add Phibro Stock to Your Portfolio Right Now

Zacks

2 months ago

Reasons to Add Phibro Stock to Your Portfolio Right Now

3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)

Zacks

2 months ago

3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)

GMED vs. PEN: Which Stock Should Value Investors Buy Now?

Zacks

2 months ago

GMED vs. PEN: Which Stock Should Value Investors Buy Now?

GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care

Zacks

2 months ago

GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care

Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues

Zacks

2 months ago

Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues

Reasons to Retain Medtronic Stock in Your Portfolio Now

Zacks

2 months ago

Reasons to Retain Medtronic Stock in Your Portfolio Now

QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site

Zacks

2 months ago

QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site

MDT Stock May Gain Following the Positive Data From Optimize PRO Study

Zacks

2 months ago

MDT Stock May Gain Following the Positive Data From Optimize PRO Study

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock

Zacks

2 months ago

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock

Hologic to Debut AI-Powered Innovations at RSNA 2024: Stock to Gain?

Zacks

2 months ago

Hologic to Debut AI-Powered Innovations at RSNA 2024: Stock to Gain?

GEHC Stock May Gain Following the Launch of Pristina Via System

Zacks

2 months ago

GEHC Stock May Gain Following the Launch of Pristina Via System

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

2 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock

Zacks

2 months ago

New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock

Argus Research

2 months ago

GMED: Raising target price to $89.00

STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System

Zacks

2 months ago

STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System

MMSI Stock Down Despite Latest Positive Data From WRAPSODY WAVE Trial

Zacks

2 months ago

MMSI Stock Down Despite Latest Positive Data From WRAPSODY WAVE Trial

BSX Stock Set to Gain From Agreement to Acquire Intera Oncology

Zacks

2 months ago

BSX Stock Set to Gain From Agreement to Acquire Intera Oncology

MT Newswires

2 months ago

Globus Medical Insider Sold Shares Worth $11,050,000, According to a Recent SEC Filing

GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio

Zacks

2 months ago

GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio

GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub

Zacks

2 months ago

GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub

Reasons to Retain IART Stock in Your Portfolio for Now

Zacks

2 months ago

Reasons to Retain IART Stock in Your Portfolio for Now

MYGN Stock Up on Integration of HRD Platform Into Illumina's TSO 500 v2

Zacks

2 months ago

MYGN Stock Up on Integration of HRD Platform Into Illumina's TSO 500 v2

Globus Medical Launches ExcelsiusHub™ Navigation System

GlobeNewswire

2 months ago

Globus Medical Launches ExcelsiusHub™ Navigation System

CAH Stock Gains on the Launch of Kendall SmartFlow Compression System

Zacks

2 months ago

CAH Stock Gains on the Launch of Kendall SmartFlow Compression System

PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US

Zacks

2 months ago

PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US

Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth

Zacks

2 months ago

Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth

Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?

Zacks

2 months ago

Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?

MDT Stock Gains From FDA Approval for Its InPen App

Zacks

2 months ago

MDT Stock Gains From FDA Approval for Its InPen App

Reasons to Retain QIAGEN Stock in Your Portfolio for Now

Zacks

2 months ago

Reasons to Retain QIAGEN Stock in Your Portfolio for Now

HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

Zacks

2 months ago

HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

ALGN Stock to Gain From CE Mark Win for Invisalign Palatal Expander

Zacks

2 months ago

ALGN Stock to Gain From CE Mark Win for Invisalign Palatal Expander

GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects

Zacks

2 months ago

GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects

End Market Growth, New Acquisitions Drive Thermo Fisher's Shares

Zacks

2 months ago

End Market Growth, New Acquisitions Drive Thermo Fisher's Shares

Stryker Stock May Gain From Oculan Lighting Platform's Launch

Zacks

2 months ago

Stryker Stock May Gain From Oculan Lighting Platform's Launch

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System

Zacks

2 months ago

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System

ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio

Zacks

2 months ago

ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio

Patterson Companies Stock Up Following Latest Partnership Extension

Zacks

2 months ago

Patterson Companies Stock Up Following Latest Partnership Extension

Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View

Zacks

2 months ago

Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View

NVRO Stock Declines Despite Positive Study Data of Nevro1 System

Zacks

2 months ago

NVRO Stock Declines Despite Positive Study Data of Nevro1 System

Reasons to Retain BSX Stock in Your Portfolio for Now

Zacks

2 months ago

Reasons to Retain BSX Stock in Your Portfolio for Now

BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX

Zacks

2 months ago

BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX

Boston Scientific Stock Set to Gain From Completion of Axonics Deal

Zacks

2 months ago

Boston Scientific Stock Set to Gain From Completion of Axonics Deal

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study

Zacks

2 months ago

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study

Here's Why You Should Add OMCL Stock to Your Portfolio Now

Zacks

2 months ago

Here's Why You Should Add OMCL Stock to Your Portfolio Now

LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint

Zacks

2 months ago

LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint

Share on Social Networks: